Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study

Our previous clinical trial showed that a novel concentrated herbal extract formula, YH1 (Rhizoma coptidis and Shen-Ling-Bai-Zhu-San), improved blood glucose and lipid control. This pilot observational study investigated whether YH1 affects microbiota, plasma, and fecal bile acid (BA) compositions i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yueh-Hsiang, Wu, Yi-Hong, Tang, Hsiang-Yu, Chen, Szu-Tah, Wang, Chih-Ching, Ho, Wan-Jing, Lin, Yi-Hsuan, Liu, Geng-Hao, Lin, Pei-Yeh, Lo, Chi-Jen, Yeh, Yuan-Ming, Cheng, Mei-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505101/
https://www.ncbi.nlm.nih.gov/pubmed/36145605
http://dx.doi.org/10.3390/pharmaceutics14091857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505101/
https://www.ncbi.nlm.nih.gov/pubmed/36145605
http://dx.doi.org/10.3390/pharmaceutics14091857

Ejemplares similares